Not medical advice. Thymosin Alpha-1 is sold for research. This guide does not recommend dosing, diagnosis, or therapy.
Thymosin α1 is researched in immune-modulation and vaccine-adjuvant contexts; literature spans innate immunity and T-cell help in animal models.
One-paragraph overview from our research datasheet—still scientific, but faster to read than the full mechanism list below.
Thymosin Alpha-1 (Zadaxin) 28-amino-acid thymic peptide activates TLR2/3/4/7/9 signaling for T-cell maturation. Approved in 30+ countries for immunomodulation.
Many readers want context before diving into pathways. The list below summarises what researchers and reviewers discuss—cells, animals, and (for some drug-class molecules) formal clinical trials. It is not a promise of results for any individual.
“Reported” means described in the literature, not recommended for personal use. Our peptides are for laboratory research only.
Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.
Below are mechanistic bullet points as they appear in our product reference material -useful for researchers comparing pathways. They are not simplified health claims.
Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. ~5% degradation per year refrigerated. - see our storage guide for best practices on temperature, light, and shelf life.
Typical research dosing discussion (literature-style): 1.6 mg (900 μg/m²) subcutaneously · Twice weekly · Subcutaneous Tmax ~2 hours. Serum t½ ~2 hours with return to baseline within 24 hours. Rapidly absorbed after SC injection. Amino acid sequence conserved across murine, bovine, and human species. Contraindicated in organ transplant recipients. Approved in 30+ countries as Zadaxin for hepatitis B/C and immune dysfunction.
For preparation, follow the step-by-step reconstitution guide and use the reconstitution calculator to confirm draw volumes. Review subcutaneous injection basics for technique, and always verify batch purity by reading the COA.
What is Thymosin Alpha-1 in plain language?
Thymosin Alpha-1 is a research peptide we catalogue under “Healing / Recovery.” This article explains how scientists discuss it in published literature and what study types usually appear—not as a consumer product claim.
Does this page give medical advice or dosing instructions for Thymosin Alpha-1?
No. Content is for laboratory and research literacy only. It does not diagnose, treat, or prevent disease, and is not a dosing guide.
Where can I see purity, variants, and pricing for Thymosin Alpha-1?
Use the “View product” button to open the canonical shop listing for Thymosin Alpha-1, where specifications and research SKU details are shown.
What about online case reports, before-and-after stories, or forum “logs” for Thymosin Alpha-1?
Those sources are not peer-reviewed evidence. This guide focuses on preclinical literature and, where relevant, formal clinical trial programmes for drug-class molecules. Anecdotes may be interesting culturally; they are not a safe basis for dosing or medical decisions.
Open the shop listing for variants, purity notes, and research SKU details.
View productAlso known as: Thymalfasin, Tα1, Ta1, Zadaxin, Thymosin α1, Thymosin Alpha 1, SciClone Thymalfasin, Immune Modulator Peptide